Phase2 study of bevacizumab with carboplatin–paclitaxel for non-small cell lung cancer with malignant pleural effusion

Details 詳細情報について

• CRID

  1360292619494242560

• DOI

  10.1007/s12032-013-0676-7

• ISSN

  1559131X

  13570560

• Web Site

  http://link.springer.com/content/pdf/10.1007/s12032-013-0676-7.pdf

  http://link.springer.com/article/10.1007/s12032-013-0676-7/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s12032-013-0676-7

• Data Source

  • Crossref